NPCE (NPCE) Stock Price & Analysis
NPCE (NPCE) rose 1.02% to USD 14.9 as of September 8, 2026 at 05:55 UTC, according to Nexqual real-time market data.
NPCE last closed at USD 14.9; the session ranged USD 14.47–14.9 on volume of 92,320 shares. Market capitalization is —, with a 52-week range of USD 9.22–19.6 (NGM). Source: Nexqual, September 8, 2026 at 05:55 UTC.
Key Statistics (as of September 8, 2026 at 05:55 UTC)
| Price | USD 14.9 |
|---|---|
| Change | ▲ 1.02% (up) |
| Previous Close | USD 14.9 |
| Open | USD 14.9 |
| Day Range | USD 14.47 – 14.9 |
| 52-Week Range | USD 9.22 – 19.6 |
| Volume | 92,320 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (NPCE)
Nexqual's technical model rates NPCE "NEUTRAL" based on 3 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 05:55 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 51.43 (neutral) |
| vs SMA50 | Below (USD 15.11) |
| MACD | -0.02 (negative) |
From NPCE's Latest SEC 10-K Filing (filed 2026-03-03)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TMCI | Treace Medical Concepts, Inc. | USD 4.81 | ▲ 2.34% |
| CVRX | CVRx, Inc. | USD 3.05 | ▼ 0.65% |
| SGHT | Sight Sciences, Inc. | USD 8.35 | ▼ 0.83% |
| LUNG | Pulmonx Corporation | USD 2.21 | ▼ 3.07% |
| BVS | Bioventus Inc. | USD 14.07 | ▼ 2.09% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:55 UTC. This page is informational and not investment advice.